Form 4 for XENE Xenon Pharmaceuticals Inc.
Accepted 2025-12-03 00:00:00 ET · period of report 2025-11-28 · accession 0001193125-25-307211 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-12-03 | 2025-11-28 | XENE | MORTIMER IAN | Pres, CEO, Dir | S - Sale | $45.01 | -97 | 31.2K | -0.3% | -$4,366 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-11-28 | S | D | 97 | $45.01 | 31,205 | D | — | — |